0

Patient Registry Software Market: Current Analysis and Forecast (2021-2027)

Region:Global

Author(s):

Product Code:UMHE21564

Download Sample Report download
Buy the Full ReportStarting from $4999
Published on

November 2021

Total pages

327

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $4999

About the Report

About the Report

Patient registry software is used to capture, manage, and provide data on specific conditions to support organized care management of patients with chronic diseases. The exploitation of medical information from clinical registries is progressively improving all over the world. Clinical registries capture broad-scope data by using a mixture of manual and automated methods. As per a survey by the American Medical Association, published in the Journal for Electronic Health Data and Methods in 2018, the Centers of Medicare and Medicaid use around 70% of data of over 50 specialty clinical registries in the US for measuring the quality of clinical care through patient registries.
The demand for the Patient Registry Software market is burgeoning on account of the increasing adoption of Electronic Health Records and other eHealth solutions all over the world. The patient registry software functionality is integrated as an add-on for many EHR products. Numerous Countries are focusing on the higher adoption of EHR solutions in their healthcare systems for the delivery of effective healthcare services. As per HealthIt.gov, nearly 9 in 10 (86%) of office-based physicians had adopted EHR, and nearly 4 in 5 (80%) had adopted a certified EHR. The rising exploitation of EHR in developed as well as developing countries is leading to improved patient care, expanded patient participation, and easy collection and storage of patient health information in a digital format. In addition, the increasing pressure to improve the quality of care and reduce healthcare costs, and the growing use of patient registry data for post-market surveillance also boost the market growth. However, some of the restraints in the market are the shortage of trained or skilled resources and privacy and data security-related concerns
Based on the Type of Registry, the market is fragmented into Disease Registry, Health Service Registry, and Product Registry. The Disease Registry segment dominated the market in 2020 and is expected to grow at lucrative growth owing to the rise in the aging population, increasing prevalence of chronic diseases, rising awareness on the role of registries in health management, and the adoption of EHRs all over the world. More than a million cancer cases are diagnosed every year and as per the American Cancer Society (2021), 1 in 3 people will be diagnosed with cancer in their lifetime.
Based on the type of Software, the market is bifurcated into Standalone and Integrated. The Standalone segment dominated the market in 2020 owing to its easy-to-use tools and advanced features. Standalone software applications focus only on a specific register for instance cardiovascular, rare disease, diabetes, and cancer patient details. Hence, it is extremely comprehensive and data retrieval is also quite easy. Moreover, the automatic upgrade feature of standalone helps to reduce IT overhead costs. The Integrated segment is expected to show significant growth during the forecast period. The Integrated system is an accumulation of software at the national level which helps to track affected geographic locations and evaluate the clinical intervention. Integrated software assists in gaining information on disease burden and the effectiveness of treatment programs. Integrated software is being gradually used in hospital settings, where multiple registries need to be recorded in different departments, and cross-sharing of this data across departments is crucial.
Based on Database Type, the market is bifurcated into Commercial and Public. The Commercial segment dominated the market in 2020 due to its enhanced data security in comparison to the public database. Also, these databases follow government standards and coding, which further intensifies the segment demand. In addition, this software provides several benefits, for instance, timely software up-gradation, single point of contact for any business problem, and ease of use. Moreover, the commercial databases provide data exchange among government research organizations for example CDC and central disease registries which are further driving the segment growth. The Public segment is expected to grow at lucrative growth during the forecasted period owing to the rising number of research organizations. Also, the database is used for specific research tasks or projects, which fuels its demand. Moreover, the software is voluntarily unpatented and uncopyrighted. For example, Registry Plus is a public database registry launched by CDC for the collection and processing of cancer data for any specific project.
Based on Functionality, the market is fragmented into Population Health Management, Health Information Exchange, Patient Care Management, Point-Of-Care, Medical Research & Clinical Studies, and Product Outcome Evaluation. The Population Health Management segment dominated the market in 2020 and is expected to grow at lucrative growth during the forecasted period owing to the rising demand for solutions supporting value-based care delivery. In the value-based care delivery model the hospitals and physicians, are paid based on patient health outcomes. Under value-based care agreements, providers are rewarded for assisting patients in the improvement of their health and reducing the occurrence of chronic disease. Population Health Management assists in standardizing physician approach, enhancing clinical outcomes, and reducing the cost of disease management, which is further intensifying the segment growth.
Based on End-use, the market is fragmented into Government & third parties, Hospitals & medical practices, private payers, pharma & medical device companies, and research organization. The Government & third-party segment dominated the market in 2020 owing to the implementation of this software by the government in both developed and developing countries to decrease the chronic disease burden. The pharma and medical device companies segment is expected to show lucrative growth during the forecast period owing to the rising adoption of patient registry software by the pharmaceutical, biotech, and medical devices companies to track real-world patient data. In addition, the data is also helpful for clinical trials and to address specific diseases.
Based on Deployment Model, the market is bifurcated into On-premise and Web/Cloud-based. The On-premise segment dominated the market in 2020 owing to its easy retrieval, data security, and ease of access. It is also useful for heavy data file transfers and system upgrades. The preference for these services is attributed to complete access to information and full control within the premise. Various research organizations and Pharmaceutical companies usually prefer on-premise solutions owing to the confidentiality of their data and customized service options. Web/cloud-based solution is expected to exhibit lucrative growth during the forecast period owing to their advanced features such as real-time tracking and remote access to data. Moreover, integration under the standard guidelines is another advantage boosting the demand for this solution. Both government and private organizations are opting for cloud-based software over on-premise nowadays. For instance, in November 2019, Google collaborated with the medical system, Ascension to analyze and store millions of patients' data from around 150 hospitals in the District of Columbia in its cloud computing platform.
For a better understanding of the market adoption of Patient Registry Software, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America is expected to dominate the Patient Registry Software market on account of the Increasing target population coupled with the rising prevalence of diseases and the need for population-based registries.
Some of the major players operating in the market include IBM Corporation, IQVIA Holdings, OpenText Corporation, Optum, Premier, Inc., ArborMetrix, FIGmd, McKesson Corporation, Syneos Health, and Dacima Software. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.

Products


Companies

IBM Corporation, IQVIA Holdings, OpenText Corporation, Optum, Premier, Inc., ArborMetrix, FIGmd, McKesson Corporation, Syneos Health, and Dacima Software

Table of Contents

Table of Contents

1 MARKET INTRODUCTION

1.1. Market Definitions

1.2. Limitation

1.3. Stake Holders

1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Patient Registry Software Market

2.2. Research Methodology of the Patient Registry Software Market

2.3. Forecasting Method

2.4. Respondent Profile

2.5. Main Objective of the Patient Registry Software Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL PATIENT REGISTRY SOFTWARE MARKET COVID-19 IMPACT

6 GLOBAL PATIENT REGISTRY SOFTWARE MARKET REVENUE (USD BN), 2019-2027F

7 MARKET INSIGHTS BY TYPES OF REGISTRY

7.1. Disease Registry

7.1.1. Cardiovascular

7.1.2. Diabetes

7.1.3. Cancer

7.1.4. Rare disease

7.1.5. Asthma

7.1.6. Others

7.2. Health Service Registry

7.3. Product Registry

7.3.1. Medical Device

7.3.2. Drug

8 MARKET INSIGHTS BY TYPE OF SOFTWARE

8.1. Standalone

8.2. Integrated

9 MARKET INSIGHTS BY DATABASE TYPE

9.1. Commercial

9.2. Public

10 MARKET INSIGHTS BY FUNCTIONALITY

10.1. Population Health Management

10.2. Health Information Exchange

10.3. Patient Care Management

10.4. Point-Of-Care

10.5. Medical Research & Clinical Studies

10.6. Product Outcome Evaluation

11 MARKET INSIGHTS BY END-USE

11.1. Government & third party

11.2. Hospitals & medical practices

11.3. private payers

11.4. pharma & medical device companies

11.5. Research organization

12 MARKET INSIGHTS BY DEPLOYMENT MODEL

12.1. On-premise

12.2. Web/Cloud-based

13 MARKET INSIGHTS BY REGION

13.1. North America Patient Registry Software Market

13.1.1. United States

13.1.2. Canada

13.1.3. Rest of North America

13.2. Europe Patient Registry Software Market

13.2.1. Germany

13.2.2. U.K.

13.2.3. France

13.2.4. Rest of Europe

13.3. Asia Pacific Patient Registry Software Market

13.3.1. China

13.3.2. Japan

13.3.3. India

13.3.4. Australia

13.3.5. Rest of Asia Pacific

13.4. Rest of World Patient Registry Software Market

14 Patient Registry Software MARKET DYNAMICS

14.1. Market Drivers

14.2. Market Challenges

14.3. Impact Analysis

15 Patient Registry Software MARKET OPPORTUNITIES

16 Patient Registry Software MARKET TRENDS

17 LEGAL & REGULATORY FRAMEWORK

18 DEMAND AND SUPPLY SIDE ANALYSIS

18.1. Demand Side Analysis

18.2. Supply Side Analysis

18.2.1. Top Product Launches

18.2.2. Top Business Partnerships

18.2.3. Top Business Expansions, Investments and Divestitures

18.2.4. Top Merger and Acquisitions

19 VALUE CHAIN ANALYSIS

20 COMPETITIVE SCENARIO

20.1. Competitive Landscape

20.1.1. Company Shares, By Revenue

21 COMPANY PROFILED

21.1. IBM Corporation

21.2. IQVIA Holdings

21.3. OpenText Corporation

21.4. Optum

21.5. Premier, Inc.

21.6. ArborMetrix

21.7. FIGmd

21.8. McKesson Corporation

21.9. Syneos Health

21.10. Dacima Software

22 DISCLAIMER

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022